- Home
- Products
- Prescription: drugs for allergy
- Calcium gluconate-Darnitsa
Calcium gluconate-Darnitsa
Release forms:
- Tablets
- Solution for injection
Hypoparathyroidism; increased calcium excretion from the body (especially during prolonged dehydration); as an adjuvant treatment in allergic diseases (serum sickness, urticaria, angioedema) and allergic complications of drug therapy; to reduce vascular permeability in pathological processes of any genesis (exudative phase of the inflammatory process, haemorrhagic vasculitis, radiation sickness); parenchymal hepatitis; toxic liver damage; nephritis; eclampsia; hyperkalemia; hyperkalemic paroxysmal myoplegia; skin diseases (pruritis, eczema, psoriasis); as a haemostatic agent; as an antidote in poisoning with magnesium salts, oxalic acid or its soluble salts, soluble fluoric acid salts.
Characteristics of the productу:
- Release formInjectable solution
- ChildrenAllowed from 14 years
- PregnantWith caution
- NursingWith caution
- Release categoryPrescription medication
- AllergicsAllowed
- Temperature storage conditionsNot higher than 25 °С
- Qualitative and quantitative composition
- Pharmaceutical form
- Pharmacotherapeutic group
- Pharmacological properties.
- Clinical particulars
- Therapeutic indications.
- Contraindications.
- Interaction with other medicinal products and other forms of interaction
- Special warnings and precautions for use
- Posology and method of administration
- Overdose.
- Undesirable effects.
- Shelf life.
- Special precautions for storage
- Incompatibilities
- Nature and contents of container
- Category of release
- Manufacturer
- The manufacturer's location and address of the place of business
- Date of last revision